Comparison of medium-weight vs heavy-weight mesh in minimally invasive extraperitoneal ventral hernia repairs - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Medium- Versus Heavyweight Mesh for Minimally Invasive Extraperitoneal Ventral Hernia Repair: A Comparative Study

  • By

  • Ayesha Siddiq

  • Nicolette M. Winder

  • Xinyan Zheng

  • Jeffrey Marks

  • Joshua L. Lyons

  • Samuel J. Zolin

  • October 15, 2026

Share

  • 1

    This retrospective study used prospectively collected ACHQC data to compare medium- and heavyweight mesh in minimally invasive extraperitoneal ventral hernia repair.

  • 2

    Eligible adults underwent laparoscopic or robotic retromuscular or preperitoneal repair with clean wounds and successful fascial closure.

  • 3

    The primary outcome was pragmatic hernia recurrence at 1 year, combining available surgeon-reported and patient-reported assessments.

  • 4

    Secondary outcomes included 30-day complications and recurrence, readmission, reoperation, pain, and abdominal-wall–specific quality of life.

  • 5

    Propensity score matching was used to balance clinical and operative characteristics between mesh-weight groups, and follow-up extended to approximately 2 years.

Original Source(s)

Comparison of medium-weight vs heavy-weight mesh in minimally invasive extraperitoneal ventral hernia repairs

  • by Ayesha Siddiq, Nicolette M. Winder, Xinyan Zheng, Jeffrey Marks, Joshua L. Lyons, Samuel J. Zolin

  • October 15, 2026

Related Content

Triple Coronary Artery Bypass Surgery: A Multidisciplinary Approach to Recovery

Coronary artery disease develops when plaque accumulates within the arteries that supply blood to the heart muscle. Genetics can play an important role, while smoking, diabetes, uncontrolled high blood pressure, inactivity, poor diet and other factors can accelerate the process.

  • by

  • October 13, 2026

  • 11 min
Precision Over Aggression: Evolving Strategies for Skull Base Tumor Treatment

For benign skull base tumors, the goal is increasingly durable tumor control with functional preservation over maximal resection.

  • by

  • October 13, 2026

  • 6 min
AI diagnostics and what clinicians can verify in oncology

"The more AI changes what we do … the less able we are to check it.”